VEGFA and neoplasm: Triphala and one of its active compounds, chebulinic acid, specifically inhibits VEGF-induced angiogenesis by suppressing VEGF receptor-2 (VEGFR-2) phosphorylation and thus reduces tumor growth and metastasis [75].